Product Information
FINGOLIMOD 0.5 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $5.3501 per EA under NDC 62756006483. Its NADAC has been published 127 times since Sep 20, 2023.
FDA first approved this application on Dec 4, 2019.
The High Outlier badge above means this manufacturer's average price in the Fingolimod market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756006483
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
FINGOLIMOD HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208014FDA Approved
12/4/2019
On Market Since
10/25/2022
Pharmacological Classes
Price Statistics
The NADAC for FINGOLIMOD 0.5 MG CAPSULE has been published 127 times since Sep 20, 2023, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.3501 per EA |
|---|---|
| All-time high | $10.0429 (May 15, 2024) |
| All-time low | $4.8168 (Jul 23, 2025) |
| 52-week high | $5.7374 |
| 52-week low | $5.0736 |
| Median price | $8.6292 |
| Average price | $7.7543 |
| Largest weekly change | +16.8% (Jul 17, 2024) |
| Weeks tracked | 127 |
| Tracking since | Sep 20, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+5.5%
3Y
N/A
5Y
N/A
All
-45.1%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 61% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FINGOLIMOD 0.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FINGOLIMOD 0.5 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $5.3501 per EA (NDC 62756006483), effective Feb 18, 2026.
How has the price of FINGOLIMOD 0.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has declined 45.1%. It has been tracked across 127 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for FINGOLIMOD 0.5 MG CAPSULE?
Since Sep 20, 2023, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has ranged from a low of $4.8168 (Jul 23, 2025) to a high of $10.0429 (May 15, 2024), with a median of $8.6292 per EA.
Are there cheaper alternatives to FINGOLIMOD 0.5 MG CAPSULE?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FINGOLIMOD 0.5 MG CAPSULE, is $2.0973 per EA — about 61% below FINGOLIMOD 0.5 MG CAPSULE.
Who manufactures FINGOLIMOD 0.5 MG CAPSULE?
FINGOLIMOD 0.5 MG CAPSULE (NDC 62756006483) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.